logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hisateru Yasui

kobe city medical center general hospital
H指数:25
被引数:5,540

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut microbiome features associated with PIK3CA-mutated colorectal cancer: A nationwide pan-cancer genomic and microbial profiling study (MONSTAR-SCREEN)

PIK3CA突变结直肠癌相关的肠道微生物组特征：一项全国性泛癌症基因组学和微生物组学分析研究（MONSTAR-SCREEN）

Scientific Reports
IF3.9
2026-10-040
OAAI
Shogen Boku; Shunsuke A. Sakai; Kentaro Sawada; Satoshi Horasawa; Ayumu Yoshikawa; Yoshiaki Nakamura; Takao Fujisawa; Riu Yamashita; Hironaga Satake; Yoshito Komatsu; Tomohiro Nishina; Manabu Shiozawa; Toshihiro Kudo; Nobuhisa Matsuhashi; Kentaro Yamazaki; Toshifumi Yamaguchi; Hisateru Yasui; Naoki Takahashi; Shigenori Kadowaki; Tadamichi Denda; Takayuki Yoshino
A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study

奥塞罗研究：一项关于regorafenib和FTD/TPI在转移性结直肠癌中治疗顺序的前瞻性观察研究

British Journal of Cancer
IF6.8
2026-09-290
PRE
Takeshi Kawakami; Toshiki Masuishi; Tetsutaro Hamano; Akihiko Chida; Seiichiro Mitani; Hisateru Yasui; Atsushi Ishiguro; Takayuki Ando; Kentaro Sawada; Kazuaki Harada; Naoki Takahashi; Shogen Boku; Tomomi Kashiwada; Taito Esaki; Ayumu Yoshikawa; Keiji Sugiyama; Kouji Yamamoto; Hironaga Satake; Satoshi Yuki; Kentaro Yamazaki; Eiji Oki
Case Report: Discordance between RNA-identified ETV6::RET and clinically reportable DNA profiling in salivary gland secretory carcinoma

病例报告：涎腺分泌性癌中RNA鉴定ETV6::RET与临床可报告的DNA分型之间的不一致

Frontiers in Oncology
IF3.3
2026-09-280
OA
SB Shogen Boku; TF Takao Fujisawa; TS Tomofumi Sakagami; SK Shigenori Kadowaki; HS Hironaga Satake; HY Hisateru Yasui; KO Koushiro Ohtsubo; YS Yasushi Shimizu; TO Tomoyuki Otsuka; BK Bunya Kuze; RY Riu Yamashita; TS Taro Shibuki; YN Yoshiaki Nakamura; HB Hideaki Bando; TY Takayuki Yoshino; MR Milan Radovich; MY Masao Yagi; SO Susumu Okano
Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用：一项前瞻性单臂II期临床试验

Communications Medicine
IF6.3
2026-09-090
OAAI
Yoshinori Kagawa; Daisuke Kotani; Hiroya Taniguchi; Tadayoshi Hashimoto; Hideaki Bando; Naoki Takahashi; Tetsuya Hamaguchi; Akiyoshi Kanazawa; Takeshi Kato; Koji Ando; Hisateru Yasui; Eiji Shinozaki; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Satoshi Yuki; Yoshiaki Nakamura; Masashi Wakabayashi; Hiromichi Nakajima; Takashi Ohta; Takayuki Yoshino
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials

Zolbetuximab联合化疗在日本Claudin 18.2阳性胃癌或胃食管结合部腺癌患者中的应用：SPOTLIGHT和GLOW III期试验的合并亚组分析

Gastric Cancer
IF5.1
2026-05-070
OAAI
Kensei Yamaguchi; Hirokazu Shoji; Hisateru Yasui; Eiji Oki; Daisuke Sakai; Tetsuya Hamaguchi; Akihito Tsuji; Takashi Oshima; Masahiro Tsuda; Keiko Minashi; Jianning Yang; Abraham Guerrero; Yoko Ueno; Maria Matsangou; Georgia Gourgioti; Yuka Nakanishi; Satomi Furuki; Kana Kuwamoto; Shunsuke Yamada; Kohei Shitara
Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes

真实世界中免疫检查点抑制剂在HPV相关和HPV非相关亚型晚期宫颈癌中的多中心研究

International Journal of Clinical Oncology
IF2.8
2025-11-260
PRE
Kazuhiro Ko; Mayu Fukuda; Koji Yamanoi; Nobutaka Hayashi; Hisateru Yasui; Takuma Hayashi; Yoshihiro Yakushijin; Takehiko Tsumura; Atsushi Shirakawa; Chiho Nakashima; Yoshinori Imamura; Chikako Yamauchi; Toshio Shimizu; Takahito Ashihara; Nobuhiro Shibata; Takeshi Kotake; Aya Toyofuku; Taito Miyamoto; Rin Mizuno; Mana Taki; Ryusuke Murakami; Satoshi Morita; Manabu Muto; Masaki Mandai
Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab

紫杉类药物联合ramucirumab治疗化疗联合nivolumab后进展的晚期胃癌的疗效与安全性

Scientific Reports
IF3.9
2025-08-070
OA
Toshihiko Matsumoto; Tatsuki Ikoma; Chinatsu Makiyama; Tomoyo Yasuda; Shogen Boku; Akio Nakasya; Nobuhiro Shibata; Hiroki Nagai; Takao Tsuduki; Yusuke Matsumoto; Hisateru Yasui; Reiji Higashi; Akitoshi Sasamoto; Hironaga Satake; Kentaro Inoue; Masashi Kanai; Makoto Yamasaki
First-line pembrolizumab plus chemotherapy for participants in Japan with gastric or gastroesophageal junction adenocarcinoma: subgroup analysis of the phase 3 KEYNOTE-859 study

日本胃癌或胃食管结合部腺癌患者的一线帕博利珠单抗联合化疗：KEYNOTE-859 III期研究的亚组分析

international journal of oncology
IF2.8
2025-08-010
PRE
Hisateru Yasui; Masaki Aizawa; Kensei Yamaguchi; Akihito Kawazoe; Hiroki Hara; Masahiro Tsuda; Hirokazu Shoji; Naotoshi Sugimoto; Nobuhiro Shibata; Kenji Amagai; Yasuhiro Choda; Shiro Iwagami; Taito Esaki; Shigenori Kadowaki; Shinichi Shiratori; Shirong Han; Sonal Bordia; Kohei Shitara
An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study

一项关于纳武利尤单抗联合化疗在未经治疗的晚期或复发性胃癌日本真实世界中的有效性与安全性观察研究：G-KNIGHT研究

Gastric Cancer
IF5.1
2025-07-090
OAAI
Shigenori Kadowaki; Tomoyuki Otsuka; Keiko Minashi; Shinichi Nishina; Hiroshi Yabusaki; Chiaki Inagaki; Tomohiro Nishina; Hisateru Yasui; Hiroshi Matsuoka; Nozomu Machida; Masahiro Tsuda; Fumio Nagashima; Hisashi Hosaka; Junichi Matsubara; Hiroyuki Arai; Satoshi Ida; Yuya Kimijima; Yuko Matsuda; Manabu Muto; Kei Muro
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR

RAS野生型转移性结直肠癌患者一线治疗临床结局的基因组范围DNA甲基化状态作为生物标志物：JACCRO CC-13AR

ESMO OPEN
IF8.3
2025-05-010
OA
Ouchi, K.; Sunakawa, Y.; Tsuji, A.; Shiozawa, M.; Kawai, T.; Yasui, H.; Ota, H.; Kochi, M.; Manaka, D.; Ohori, H.; Miyake, T.; Yamaguchi, T.; Matsuura, M.; Sagawa, T.; Makiyama, A.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Ishioka, C.
A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer

一项二期临床试验，评估在FOLFOXIRI联合贝伐珠单抗失败后，FOLFIRI联合阿柏西普对不可切除性转移性结直肠癌患者的疗效。

international journal of oncology
IF2.8
2025-02-010
PRE
Ando, Koji; Satake, Hironaga; Shimokawa, Mototsugu; Yasui, Hisateru; Negoro, Yuji; Kinjo, Tatsuya; Kizaki, Junya; Baba, Kenji; Orita, Hiroyuki; Hirata, Keiji; Sakamoto, Sanae; Makiyama, Akitaka; Saeki, Hiroshi; Tsuji, Akihito; Baba, Hideo
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial
NATURE COMMUNICATIONS
IF15.7
2024-11-250
OAAI
Shiozawa, Manabu; Sunakawa, Yu; Watanabe, Takanori; Ota, Hirofumi; Yasui, Hisateru; Yabuno, Taichi; Tei, Mitsuyoshi; Kochi, Mitsugu; Manaka, Dai; Ohori, Hisatsugu; Yamaguchi, Tatsuro; Sagawa, Tamotsu; Kotaka, Masahito; Kubota, Yutaro; Sekikawa, Takashi; Nakamura, Masato; Takeuchi, Masahiro; Ichikawa, Wataru; Fujii, Masashi; Tsuji, Akihito
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors

循环肿瘤DNA分析指导下的晚期消化道肿瘤靶向治疗

NATURE MEDICINE
IF50
2024-09-162
OAAI
Nakamura, Yoshiaki; Ozaki, Hiroshi; Ueno, Makoto; Komatsu, Yoshito; Yuki, Satoshi; Esaki, Taito; Taniguchi, Hiroya; Sunakawa, Yu; Yamaguchi, Kensei; Kato, Ken; Denda, Tadamichi; Nishina, Tomohiro; Takahashi, Naoki; Satoh, Taroh; Yasui, Hisateru; Satake, Hironaga; Oki, Eiji; Kato, Takeshi; Ohta, Takashi; Matsuhashi, Nobuhisa; Goto, Masahiro; Okano, Naohiro; Ohtsubo, Koushiro; Yamazaki, Kentaro; Yamashita, Riu; Iida, Naoko; Yuasa, Mihoko; Bando, Hideaki; Yoshino, Takayuki
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC

Quattro-ii随机试验: CAPOXIRI bevacizumab与FOLFOXIRI bevacizumab作为mCRC患者的一线治疗

MED
IF11.8
2024-09-010
OA
Bando, Hideaki; Kotani, Daisuke; Satake, Hironaga; Hamaguchi, Tetsuya; Shiozawa, Manabu; Kotaka, Masahito; Masuishi, Toshiki; Yasui, Hisateru; Kagawa, Yoshinori; Komatsu, Yoshito; Oki, Eiji; Yamamoto, Yoshiyuki; Kawakami, Hisato; Misumi, Toshihiro; Taniguchi, Hiroya; Yamazaki, Kentaro; Muro, Kei; Yoshino, Takayuki; Kato, Takeshi; Tsuji, Akihito
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy

与NeoRAS野生型转移性结直肠癌相关的临床特征scrum-japan GOZILA子研究

NATURE COMMUNICATIONS
IF15.7
2024-07-131
OAAI
Osumi, Hiroki; Shinozaki, Eiji; Nakamura, Yoshiaki; Esaki, Taito; Yasui, Hisateru; Taniguchi, Hiroya; Satake, Hironaga; Sunakawa, Yu; Komatsu, Yoshito; Kagawa, Yoshinori; Denda, Tadamichi; Shiozawa, Manabu; Satoh, Taroh; Nishina, Tomohiro; Goto, Masahiro; Takahashi, Naoki; Kato, Takeshi; Bando, Hideaki; Yamaguchi, Kensei; Yoshino, Takayuki
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
CLINICAL COLORECTAL CANCER
IF3.2
2024-06-010
OAAI
Yuki, Satoshi; Yamazaki, Kentaro; Sunakawa, Yu; Taniguchi, Hiroya; Bando, Hideaki; Shiozawa, Manabu; Nishina, Tomohiro; Yasui, Hisateru; Kanazawa, Akiyoshi; Ando, Koji; Horita, Yosuke; Goto, Masahiro; Okano, Naohiro; Moriwaki, Toshikazu; Satoh, Taroh; Tsuji, Akihito; Yamashita, Kaname; Asano, Chiharu; Abe, Yukiko; Nomura, Shogo; Yoshino, Takayuki

研究方向

暂未获取到该数据
H
Hironaga Satake
H 指数:24论文数:314被引数:3,551
A
Akihito Tsuji
H 指数:40论文数:426被引数:1.0万
Y
Yu Sunakawa
H 指数:32论文数:478被引数:3,973
M
Masahiro Tsuda
H 指数:41论文数:247被引数:9,272
T
Toshihiko Matsumoto
H 指数:10论文数:116被引数:621
K
Kei Muro
H 指数:80论文数:1,040被引数:4.3万
H
Hideaki Bando
H 指数:42论文数:595被引数:7,469
T
Tatsuki Ikoma
H 指数:5论文数:88被引数:121
W
Wataru Ichikawa
H 指数:33论文数:284被引数:3,624
M
Manabu Shiozawa
H 指数:38论文数:529被引数:6,169